noscript

News and Announcements

Proteomics PromarkerD Development Advances in China

  • Published June 14, 2016 2:06PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

14th June 2016, ASX Announcement

Highlights:

  • PILL and its Chinese partner Newsummit Biopharma have secured funding towards development for an In vitro Diagnostic (IVD) kit for PromarkerD in China.
  • Chinese patent granted for PromarkerD as a predictive and diagnostic test for diabetic kidney disease.
  •  Initial tranche of funding under the PILL-NSB agreement will  support the first stage of PromarkerD IVD kit manufacture.
  • China is a key global market for PILL – WHO estimates 120m Chinese have diabetes and are at risk of kidney disease.

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce significant advances towards commercialisation of PromarkerD as an In vitrro Diagnostic (IVD) test in China, with the grant of a key patent and funds secured to initiate kit manufacture.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now